• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在帕金森病中,单个多巴胺能神经元显示出铁水平升高。

Individual dopaminergic neurons show raised iron levels in Parkinson disease.

作者信息

Oakley A E, Collingwood J F, Dobson J, Love G, Perrott H R, Edwardson J A, Elstner M, Morris C M

机构信息

Institute for Ageing and Health, Newcastle University, Newcastle upon Tyne, UK.

出版信息

Neurology. 2007 May 22;68(21):1820-5. doi: 10.1212/01.wnl.0000262033.01945.9a.

DOI:10.1212/01.wnl.0000262033.01945.9a
PMID:17515544
Abstract

OBJECTIVE

Evidence suggests that abnormal iron metabolism is associated with Parkinson disease (PD), with raised iron levels found in pathologically affected areas in PD. It is unknown if this elevated iron is actually associated with neurons or reactive glia, and we therefore addressed this issue by determining if raised iron was present in single dopaminergic neurons.

METHODS

We used unfixed frozen sections from postmortem tissue of PD patients and elderly normal individuals to avoid metal contamination and translocation. Levels of iron and other elements were measured using sensitive and specific wavelength dispersive electron probe x-ray microanalysis coupled with cathodoluminescence spectroscopy in individual substantia nigra dopaminergic neurons.

RESULTS

We identified raised intraneuronal iron in single defined substantia nigra neurons in PD (mean neuronal iron 2,838 vs 1,611, p < 0.0001) but not in other movement disorders such as Huntington disease. These findings were unrelated to the density of remaining neurons.

CONCLUSIONS

Primary changes in neuronal iron could lead to neurodegeneration in Parkinson disease.

摘要

目的

有证据表明,铁代谢异常与帕金森病(PD)相关,在PD病理受累区域发现铁水平升高。目前尚不清楚这种升高的铁是否实际上与神经元或反应性胶质细胞有关,因此我们通过确定单个多巴胺能神经元中是否存在铁升高来解决这个问题。

方法

我们使用PD患者和老年正常个体尸检组织的未固定冰冻切片,以避免金属污染和移位。在单个黑质多巴胺能神经元中,使用灵敏且特异的波长色散电子探针X射线微分析结合阴极发光光谱法测量铁和其他元素的水平。

结果

我们在PD的单个明确的黑质神经元中发现神经元内铁升高(平均神经元铁含量为2838,而对照组为1611,p<0.0001),但在其他运动障碍如亨廷顿病中未发现。这些发现与剩余神经元的密度无关。

结论

神经元铁的原发性变化可能导致帕金森病中的神经退行性变。

相似文献

1
Individual dopaminergic neurons show raised iron levels in Parkinson disease.在帕金森病中,单个多巴胺能神经元显示出铁水平升高。
Neurology. 2007 May 22;68(21):1820-5. doi: 10.1212/01.wnl.0000262033.01945.9a.
2
Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra.帕金森病黑质中脑源性神经营养因子信使核糖核酸表达降低。
Exp Neurol. 2000 Nov;166(1):127-35. doi: 10.1006/exnr.2000.7483.
3
p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain.帕金森病患者大脑中的p53蛋白、γ干扰素和核因子κB水平升高。
Neurosci Lett. 2007 Feb 27;414(1):94-7. doi: 10.1016/j.neulet.2006.12.003. Epub 2006 Dec 29.
4
Peripheral iron dextran induced degeneration of dopaminergic neurons in rat substantia nigra.外周右旋糖酐铁诱导大鼠黑质多巴胺能神经元变性。
Neurochem Int. 2007 Jul;51(1):32-6. doi: 10.1016/j.neuint.2007.03.006. Epub 2007 Mar 31.
5
The role of iron in Parkinson disease and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity.铁在帕金森病和1-甲基-4-苯基-1,2,3,6-四氢吡啶毒性中的作用。
IUBMB Life. 1999 Aug;48(2):139-41. doi: 10.1080/713803493.
6
The role of iron in senescence of dopaminergic neurons in Parkinson's disease.铁在帕金森病多巴胺能神经元衰老中的作用。
J Neural Transm Suppl. 1993;40:57-67.
7
Iron histochemistry of the substantia nigra in Parkinson's disease.帕金森病中黑质的铁组织化学
Neurodegeneration. 1994 Dec;3(4):277-82.
8
An altered histaminergic innervation of the substantia nigra in Parkinson's disease.帕金森病中黑质组胺能神经支配的改变。
Exp Neurol. 2000 May;163(1):20-30. doi: 10.1006/exnr.2000.7362.
9
Iron metabolism and Parkinson's disease.铁代谢与帕金森病。
Mov Disord. 1998;13 Suppl 1:39-45.
10
Relationship among alpha-synuclein accumulation, dopamine synthesis, and neurodegeneration in Parkinson disease substantia nigra.帕金森病黑质中α-突触核蛋白积聚、多巴胺合成与神经退行性变之间的关系。
J Neuropathol Exp Neurol. 2006 Aug;65(8):808-15. doi: 10.1097/01.jnen.0000230520.47768.1a.

引用本文的文献

1
Iron mishandling in the brain and periphery in Parkinson's disease.帕金森病中大脑和外周铁处理不当
NPJ Parkinsons Dis. 2025 Aug 18;11(1):246. doi: 10.1038/s41531-025-01089-7.
2
Ferroptosis and Iron Homeostasis: Molecular Mechanisms and Neurodegenerative Disease Implications.铁死亡与铁稳态:分子机制及对神经退行性疾病的影响
Antioxidants (Basel). 2025 Apr 28;14(5):527. doi: 10.3390/antiox14050527.
3
Sex differences in peripheral and central dysregulation of the kynurenine pathway in Parkinson's disease.帕金森病中犬尿氨酸途径外周和中枢失调的性别差异。
NPJ Parkinsons Dis. 2025 May 6;11(1):116. doi: 10.1038/s41531-025-00949-6.
4
Pulling back the mitochondria's iron curtain.拉开线粒体的“铁幕”。
NPJ Metab Health Dis. 2025;3(1):6. doi: 10.1038/s44324-024-00045-y. Epub 2025 Mar 4.
5
Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases.神经退行性疾病中铁及其他金属离子的稳态与代谢
Signal Transduct Target Ther. 2025 Feb 3;10(1):31. doi: 10.1038/s41392-024-02071-0.
6
Hemochromatosis neural archetype reveals iron disruption in motor circuits.血色病神经原型揭示了运动回路中铁的紊乱。
Sci Adv. 2024 Nov 22;10(47):eadp4431. doi: 10.1126/sciadv.adp4431.
7
Trends on Novel Targets and Nanotechnology-Based Drug Delivery System in the Treatment of Parkinson's disease: Recent Advancement in Drug Development.新型靶点及基于纳米技术的药物传递系统治疗帕金森病的研究进展:药物研发的新进展。
Curr Drug Targets. 2024;25(15):987-1011. doi: 10.2174/0113894501312703240826070530.
8
Nanoscale synchrotron x-ray analysis of intranuclear iron in melanised neurons of Parkinson's substantia nigra.利用纳米同步辐射 X 射线分析帕金森病黑质核内铁。
Commun Biol. 2024 Aug 20;7(1):1024. doi: 10.1038/s42003-024-06636-1.
9
The Irony of Iron: The Element with Diverse Influence on Neurodegenerative Diseases.铁的讽刺:对神经退行性疾病有多种影响的元素
Int J Mol Sci. 2024 Apr 12;25(8):4269. doi: 10.3390/ijms25084269.
10
Common and Trace Metals in Alzheimer's and Parkinson's Diseases.阿尔茨海默病和帕金森病中的常见和痕量金属。
Int J Mol Sci. 2023 Oct 29;24(21):15721. doi: 10.3390/ijms242115721.